Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04569708 · ClinicalTrials.gov registry record · NA
Sleep Spindles and Memory in Rolandic Epilepsy
A NA study of Epilepsy and Epilepsy; Seizure, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04569708: Recruiting NA study of Epilepsy and Epilepsy; Seizure, sponsored by Massachusetts General Hospital.
NCT04569708 is a NA study of Epilepsy and Epilepsy; Seizure that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 100 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04569708, a NA study of Epilepsy and Epilepsy; Seizure, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are recruiting children with Rolandic epilepsy and children without epilepsy (aged 4 years old and above) for a non-invasive brain imaging study using Magnetic Resonance Imaging (MRI), Magnetoencephalography/Electroencephalography (MEG/EEG), and experimental tasks. The investigators hope to determine the brain circuits and brain rhythms affected in these children and ultimately identify new treatment options for childhood epilepsy patients.
Conditions Studied
Interventions
- OTHER Auditory stimulation
Study Locations (1)
Massachusetts
- Athinoula A. Martinos Center Biomedical Imaging - Charlestown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-01-16 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT04569708 shows while recruiting
NCT04569708 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (89% lower).
The record links to 6 conditions, with Epilepsy appearing as the primary indexed condition, and to 1 intervention - of which Auditory stimulation is the first listed.
NCT04569708 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04569708 about?
NCT04569708 is a clinical study titled "Sleep Spindles and Memory in Rolandic Epilepsy". The investigators are recruiting children with Rolandic epilepsy and children without epilepsy (aged 4 years old and above) for a non-invasive brain imaging study using Magnetic Resonance Imaging (MRI), Magnetoencephalography/Electroencephalography (MEG/EEG), and experimental tasks. The investigator...
What is the current status of trial NCT04569708?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2021-01-16. Estimated completion is 2025-12-31.
What conditions does trial NCT04569708 study?
This clinical trial studies the following conditions: Epilepsy, Epilepsy; Seizure, Rolandic Epilepsy, Rolandic Epilepsy, Benign, Centrotemporal Epilepsy.
What interventions are being tested in trial NCT04569708?
The interventions under investigation include: Auditory stimulation (OTHER).
Who is sponsoring clinical trial NCT04569708?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04569708 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04569708's enrollment target sits among peer trials
100 54th of 160 higher than 103 of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SeizEAR Safety Study
RECRUITING · NA
-
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
RECRUITING · NA
-
Subcortical Arousal in Perceptual Awareness
RECRUITING · NA
-
Prediction of Anxiety and Memory State
RECRUITING · NA
-
Implementation and Cost Evaluation of Project UPLIFT
RECRUITING · NA
-
Amygdala Memory Enhancement
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI